Core One Labs Completes Acquisition of Vocan Biotechnologies Inc.
VANCOUVER, BC / ACCESSWIRE / December 31, 2020 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)(WKN:A2P8K3) (the "Company") is pleased to...
News
Sona Nanotech Receives CE Mark Approval for its Rapid COVID-19 Antigen Test
Halifax, Nova Scotia--(Newsfile Corp. - December 31, 2020) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company", "Sona") a...
Presidio Announces Appointment of Christine Komola as New CFO
NEW YORK--(BUSINESS WIRE)--Presidio, Inc., a leading North American IT solutions provider, today announced that industry veteran Christine Komola is joining...
Novamind to Present at the SNN Network Canada Virtual Event on January 7, 2021
Novamind anticipates trading on the CSE under the symbol ‘NM' on January 5, 2021 TORONTO, ON / ACCESSWIRE / December...
Conformis, Inc. to Participate in Upcoming Investor Conferences
BILLERICA, Mass., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leader in patient-specific knee and hip instrumentation...
Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Vaccine Development Program and Files Trademark Application for The Complete Vaccine™
The trademark application can be found at USPTO.gov by searching “Complete Vaccine” in the Trademark Electronic Search System (TESS)Ii-Key-SARS-CoV-2 vaccine...
Judge Rules Cannabis Patients May Not be Penalized for Cannabis Use While in Custody
NM Judge affirms use of medical cannabis while in custody or under supervision of state and local governmentsALBUQUERQUE, N.M., Dec....
Immunicum AB (publ) Receives FDA Orphan Drug Designation for Ilixadencel as a Treatment for Hepatocellular Carcinoma (HCC)
Press Release 31 December 2020 Immunicum AB (publ) Receives FDA Orphan Drug Designation for Ilixadencel as a Treatment for Hepatocellular...
Skylight Health Provides 2020 Corporate Overview and 2021 Outlook
Skylight Health is a US healthcare services and technology company providing multi-disciplinary care to over 135,000 patients across 15 statesIn...
Total number of shares and voting rights in Zealand Pharma at December 31, 2020
Company announcement – No. 64 / 2020 Copenhagen, December 31, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20...
Lexicon Pharmaceuticals Announces Commencement of Dosing in Phase 2 Clinical Study of LX9211 in Post-Herpetic Neuralgia
THE WOODLANDS, Texas, Dec. 31, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today the commencement of patient...
Clubhouse Media Group Looks Back on 2020’s Big Branding Deals as Traction Builds for 2021
LOS ANGELES, Dec. 31, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Tongji Healthcare Group, Inc. (OTCMKTS:TONJ) (name change to “Clubhouse...
Axsome Therapeutics Initiates ACCORD Phase 3 Trial of AXS-05 in Alzheimer’s Disease Agitation
ACCORD is the second pivotal trial of AXS-05 in Alzheimer’s disease agitation No treatments are currently approved for Alzheimer’s disease...
Dr. John Fahy Joins Revive Therapeutics as Scientific and Clinical Advisor for COVID-19 FDA Phase 3 Study
TORONTO, Dec. 31, 2020 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty...
Helius Medical Technologies, Inc. Announces Reverse Stock Split
NEWTOWN, Pa., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech...
Histogen Announces Pricing of $14.0 Million Upsized Public Offering
SAN DIEGO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (Nasdaq: HSTO), a clinical-stage therapeutics company focused on developing potential...
Axsome Therapeutics Announces Positive Efficacy and Safety Results from the Phase 3 MOVEMENT Long-Term Trial of AXS-07 in the Acute Treatment of Migraine
Over 21,000 migraine attacks treated with AXS-07 Achieved migraine pain relief in approximately 70% of patients, and pain freedom in...
MedMira Announces Product Update
HALIFAX, Nova Scotia, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR), is pleased to announce its...
Eve & Co Announces CAD$1M Private Financing
STRATHROY, Ontario, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Eve & Co. Incorporated (TSXV: EVE) (OTCQX: EEVVF) (the “Company” or “Eve...
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update
Common stock of the merged company, Clene Inc., to commence trading on the NASDAQ Capital Market under the ticker symbol...